Thymogen (1mg)

Thymagen, also known as Thymogen, stands as a dipeptide bioregulator primarily influencing the thymus and the immune system. Initially extracted from calf thymus, Thymagen is presently manufactured using recombinant DNA techniques. In Russia, Thymagen has been extensively examined for its potential in cancer treatment by modulating the body’s innate immune response. Encouragingly, it has exhibited promise in addressing heart disease, diabetes, and post-operative care, aiming to enhance surgical outcomes.

Extensive research underscores its capacity to stimulate the immune response against numerous viruses and various bacterial infections. Notably, Thymagen has demonstrated efficacy in the treatment of Hepatitis B and C, showcasing its potential in combating these infections.